{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T04:19:47Z","timestamp":1792037987439,"version":"4.4.0"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"30","license":[{"start":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T00:00:00Z","timestamp":1659052800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Adenocarcinoma is a non\u2013small-cell lung cancer that is common cancer in both genders, and has poor clinical outcomes. We aimed to evaluate the role of cytoskeleton-associated protein 2 (CKAP2), its prognostic significance, and the relationship between CKAP2 expression and lung adenocarcinoma driver genes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>The expression of CKAP2 was studied by immunohistochemical staining of specimens from 88 patients with lung adenocarcinoma. The correlation between clinicopathological features and CKAP2 expression was analyzed. Kaplan-Meier analysis and Cox proportional hazard models were used to examine the prognostic value of CKAP2 in terms of overall survival (OS). The correlation between epidermal growth factor receptor (EGFR) mutation, anaplastic lymphoma kinase (ALK) rearrangement, and CKAP2 expression was analyzed. All histological samples were detected by fluorescence in situ hybridization for EGFR mutations and ALK rearrangements.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Eighty-eight patients with positive CKAP2 expression were observed in this study. Patients with high levels of CKAP2 expression were associated with OS (<jats:italic toggle=\"yes\">P<\/jats:italic> = .021). Multivariate Cox regression analysis disclosed that positive CKAP2 expression (<jats:italic toggle=\"yes\">P<\/jats:italic> = .043) could independently predict unfavorable OS. In addition, CKAP2 expression was not associated with EGFR mutation (<jats:italic toggle=\"yes\">P<\/jats:italic> = .219) and ALK rearrangement (<jats:italic toggle=\"yes\">P<\/jats:italic> = .389) in lung adenocarcinoma patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>High expression of CKAP2 may serve as a marker of poor prognosis in lung adenocarcinoma.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000029796","type":"journal-article","created":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T22:08:39Z","timestamp":1660169319000},"page":"e29796","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["CKAP2 overexpression correlates with worse overall survival in patients with lung adenocarcinoma"],"prefix":"10.1097","volume":"101","author":[{"given":"Sen","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Oncology, First Affiliated Hospital of Yangtze University, Jingzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Oncology, First Affiliated Hospital of Yangtze University, Jingzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghua","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Oncology, First Affiliated Hospital of Yangtze University, Jingzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Oncology, First Affiliated Hospital of Yangtze University, Jingzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenshi","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Oncology, First Affiliated Hospital of Yangtze University, Jingzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoquan","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Oncology, First Affiliated Hospital of Yangtze University, Jingzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of Oncology, First Affiliated Hospital of Yangtze University, Jingzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,7,29]]},"reference":[{"key":"R1-20250504","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"68","author":"Bray","year":"2018","journal-title":"CA: Cancer J Clin"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/ijc.21183","article-title":"International lung cancer trends by histologic type: male:female differences diminishing and adenocarcinoma rates rising.","volume":"117","author":"Devesa","year":"2005","journal-title":"Int J Cancer"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"e342","DOI":"10.1016\/S1470-2045(15)00077-7","article-title":"Genomic alterations in lung adenocarcinoma.","volume":"16","author":"Devarakonda","year":"2015","journal-title":"Lancet Oncol"},{"key":"R4-20250504","first-page":"7","article-title":"Cancer statistics, 2019.","volume":"69","author":"Siegel","year":"2019","journal-title":"CA: Cancer J Clin"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/978-3-319-40389-2_3","article-title":"Lung cancer staging and prognosis.","volume":"170","author":"Woodard","year":"2016","journal-title":"Cancer Treat Res"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/sj.onc.1202048","article-title":"Identification of a novel cDNA, encoding a cytoskeletal associated protein, differentially expressed in diffuse large B cell lymphomas.","volume":"17","author":"Maouche-Chretien","year":"1998","journal-title":"Oncogene"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/j.1349-7006.2004.tb02187.x","article-title":"Identification of a mouse cytoskeleton-associated protein, CKAP2, with microtubule-stabilizing properties.","volume":"95","author":"Jin","year":"2004","journal-title":"Cancer Sci"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3858\/emm.2008.40.4.377","article-title":"Transient phosphorylation of tumor-associated microtubule-associated protein (TMAP)\/cytoskeleton-associated protein 2 (CKAP2) at Thr-596 during early phases of mitosis.","volume":"40","author":"Hong","year":"2008","journal-title":"Exp Mol Med"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.bbrc.2006.07.046","article-title":"A cytoskeleton-associated protein, TMAP\/CKAP2, is involved in the proliferation of human foreskin fibroblasts.","volume":"348","author":"Jeon","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1073\/pnas.98.2.629","article-title":"Serological detection of cutaneous T-cell lymphoma-associated antigens.","volume":"98","author":"Eichmuller","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s00432-003-0484-0","article-title":"Up-regulation of cytoskeletal-associated protein 2 in primary human gastric adenocarcinomas.","volume":"129","author":"Bae","year":"2003","journal-title":"J Cancer Res Clin Oncol"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.4161\/cc.6.19.4753","article-title":"Chromosomal instability in cancer: causality and interdependence.","volume":"6","author":"Venkitaraman","year":"2007","journal-title":"Cell cycle (Georgetown, Tex)"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1136\/jcp.51.10.716","article-title":"Proliferation markers in tumors: interpretation and clinical value.","volume":"51","author":"van Diest","year":"1998","journal-title":"J Clin Pathol"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"6685","DOI":"10.1158\/0008-5472.CAN-04-4223","article-title":"Ckap2 regulates aneuploidy, cell cycling, and cell death in a p53-dependent manner.","volume":"65","author":"Tsuchihara","year":"2005","journal-title":"Cancer Res"},{"key":"R15-20250504","first-page":"2036","article-title":"CKAP2 expression is associated with glioma tumor growth and acts as a prognostic factor in high-grade glioma.","volume":"40","author":"Wang","year":"2018","journal-title":"Oncol Rep"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"e0182107","DOI":"10.1371\/journal.pone.0182107","article-title":"CKAP2 (cytoskeleton-associated protein2) is a new prognostic marker in HER2-negative luminal type breast cancer.","volume":"12","author":"Sim","year":"2017","journal-title":"PLoS One"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"e193","DOI":"10.1038\/emm.2015.79","article-title":"Clinical implications of proliferation activity in T1 or T2 male gastric cancer patients.","volume":"47","author":"Kim","year":"2015","journal-title":"Exp Mol Med"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"e98160","DOI":"10.1371\/journal.pone.0098160","article-title":"Chromatin CKAP2, a new proliferation marker, as an independent prognostic indicator in breast cancer.","volume":"9","author":"Kim","year":"2014","journal-title":"PLoS One"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.3892\/or.2017.5534","article-title":"Cross-validation of genes potentially associated with overall survival and drug resistance in ovarian cancer.","volume":"37","author":"Gao","year":"2017","journal-title":"Oncol Rep"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1089\/dna.2017.3876","article-title":"CKAP2 promotes ovarian cancer proliferation and tumorigenesis through the FAK-ERK pathway.","volume":"36","author":"Zhang","year":"2017","journal-title":"DNA Cell Biol"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.biopha.2018.07.104","article-title":"Silencing of cytoskeleton-associated protein 2 represses cell proliferation and induces cell cycle arrest and cell apoptosis in osteosarcoma cell.","volume":"106","author":"Zhang","year":"2018","journal-title":"Biomed Pharmacother"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000029796","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:13:02Z","timestamp":1746331982000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000029796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,29]]},"references-count":21,"journal-issue":{"issue":"30","published-online":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000029796","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,29]]}}}